Maj Hedtjärn is an Entrepreneur in Residence for the CurE-me project in BII’s Bio Studio program, a project focusing on developing an organoid platform for identifying and screening targets against endometriosis.

She holds a Ph.D. in neuroimmunology from the University of Gothenburg and runs her own consulting company for life science start-ups and biotech companies. Previously, she worked as a VP and Head of Drug Discovery at Roche Innovation Center before she became COO and head of R&D operations at Scandion Oncology.